Chemogenomic Screen for Imipenem Resistance in Gram-Negative Bacteria
ABSTRACT Carbapenem-resistant Gram-negative bacteria are considered a major threat to global health. Imipenem (IMP) is used as a last line of treatment against these pathogens, but its efficacy is diminished by the emergence of resistance. We applied a whole-genome screen in Escherichia coli, Klebsi...
Enregistré dans:
Auteurs principaux: | Jessica Y. El Khoury, Alexandra Maure, Hélène Gingras, Philippe Leprohon, Marc Ouellette |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a933a8c7d8e94f08abc8a8366fe32f0a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?
par: Aleksandra Rapacka-Zdonczyk, et autres
Publié: (2021) -
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
par: Christopher Fröhlich, et autres
Publié: (2019) -
Susceptibilidad antimicrobiana de cepas de Pseudomonas aeruginosa aisladas en el laboratoriodel Hospital Regional Dr. Leonardo Guzmán de Antofagasta, Chile
par: ZAMBRANO F.,ALCIDES, et autres
Publié: (2004) -
Caracterización molecular de Escherichia coli y Klebsiella pneumoniae productores de ß-lactamasas de espectro extendido en hospitales de la Región Caribe, Colombia
par: Gaitán C,Sandra L, et autres
Publié: (2009) -
A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World
par: Michael P. Motley, et autres
Publié: (2017)